|
|
 Advisory Board
Roger Cohen, M.D.
Dr. Cohen is Professor of Medicine and Director of Phase I Trials at Fox
Chase Cancer Center. Previously, Dr. Cohen was Director of Clinical
Trials at the University of Virginia Cancer Center and was Deputy
Director of the Division of Monoclonal Antibodies at the FDA Center for
Biologics Evaluation and Research. Dr. Cohen is an expert in the design,
conduct, and analysis of all phases of clinical trials, and has
consulted for many pharmaceutical and biotechnology companies.
|
|